A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy
Trial details
- Registry ID
- NCT07096843
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as TNT119
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Phase 2 Study of Budoprutug in Subjects With Primary Membranous NephropathyNCT07096843 | CLYM | Phase 2 | Recruiting | 2027-10Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |